[R-1625: a new drug for the symptomatic treatment of psychomotor excitation].
D006220:Haloperidol; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D011595:Psychomotor Agitation
D006993:Hypnotics and Sedatives; D006220:Haloperidol
HYPNOTICS AND SEDATIVES/therapeutic use
Le R 1625: nouvelle thérapeutique symptomatique de l'agitation psychomotrice.